Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of C3AR1 as a biomarker in methods of treating inflammatory response syndromes

Use of C3AR1 as a biomarker in methods of treating inflammatory response syndromes

US Patent 10975437 · Granted Apr 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating or inhibiting severe sepsis based on measuring defensin alpha 4 (DEFA4)2024
Treating or inhibiting severe sepsis based on measuring defensin alpha 4 (DEFA4)2024
Pathogen biomarkers and uses therefor2024
Pathogen biomarkers and uses therefor2024
Biomarker signature method, and apparatus and kits thereof2021
Biomarker signature method, and apparatus and kits thereof2021
Biomarker signature method, and apparatus and kits therefor2020
Biomarker signature method, and apparatus and kits therefor2020
Validating biomarker measurement2020
Microbial markers and uses therefor2019
Biomarker identification2019
Biomarker identification2019